| 今开：42.18 | 昨收：42.41 |
| 最高：42.72 | 最低：41.49 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.547117369E9 |
Soleno Therapeutics(SLNO)04-04 09:45
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010247 Size: 7 KB 网页链接查看全文
Soleno Therapeutics(SLNO)04-04 09:45
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010250 Size: 7 KB 网页链接查看全文
Soleno Therapeutics(SLNO)04-23 05:15
$Soleno Therapeutics(SLNO)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-046496 Act: 34 Size: 606 KB 网页链接查看全文
Soleno Therapeutics(SLNO)06-11 08:55
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016312 Size: 5 KB 网页链接查看全文
Soleno Therapeutics(SLNO)05-03 04:05
$Soleno Therapeutics(SLNO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-129348 Act: 33 Size: 1 MB 网页链接查看全文
Soleno Therapeutics(SLNO)05-01 06:05
$Soleno Therapeutics(SLNO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-011794 Size: 13 KB 网页链接查看全文
Soleno Therapeutics(SLNO)05-07 05:05
$Soleno Therapeutics(SLNO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-132008 Act: 33 Size: 1 MB 网页链接查看全文
Soleno Therapeutics(SLNO)05-10 18:05
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-135478 Act: 34 Size: 226 KB 网页链接查看全文
Soleno Therapeutics(SLNO)04-30 04:15
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-122237 Act: 34 Size: 161 KB 网页链接查看全文
人生真谛2023-09-26 21:57
$Soleno Therapeutics(SLNO)$ 索莱诺治疗提供公司更新并报告2023年第一季度财务业绩
9月 2023， <>
英文版
加利福尼亚州红木城，09年2023月31日（环球通讯社）--Soleno Therapeutics，Inc.（Soleno）（纳斯达克股票代码：SLNO）...查看全文
$Soleno Therapeutics(SLNO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-23-247525 Act: 33 Size: 735 KB 网页链接
$Soleno Therapeutics(SLNO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-23-246102 Act: 34 Size: 80 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-080555 Size: 9 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-018574 Size: 36 KB 网页链接
$Soleno Therapeutics(SLNO)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-23-244707 Act: 34 Size: 8 KB 网页链接
$Soleno Therapeutics(SLNO)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-23-244711 Act: 34 Size: 8 KB 网页链接
$Soleno Therapeutics(SLNO)$ S-3MEF Registration adding securities to prior Form S-3 registration [Rule 462(b)] Accession Number: 0001193125-23-244319 Act: 33 Size: 85 KB 网页链接
$Soleno Therapeutics(SLNO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-23-243893 Act: 33 Size: 778 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 1.02 and 8.01 Accession Number: 0001193125-23-243881 Act: 34 Size: 145 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-23-241845 Act: 34 Size: 192 KB 网页链接